A large Canadian study found that regular exercise after colon cancer treatment reduces the risk of cancer returning. Patients who followed a structured exercise program had higher survival rates than ...

A new use for a common painkiller. A medication prescribed to treat pain appears to have the power to keep cancer at bay. Celebrex is an anti-inflammatory used to alleviate symptoms of arthritis, ...

Jan 31 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

A landmark 17-year study has found that a workable exercise plan significantly improves survival and enduring health of people who have experienced colorectal cancer. So much so that, as one of the ...

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...

Dana-Farber Cancer Institute. "Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence." ScienceDaily. ScienceDaily, 28 January 2025. <www.sciencedaily ...

June 3 -- MONDAY, June 2 (HealthDay News) -- Long-term smokers treated for advanced colon cancer are at increased risk for cancer recurrence, a Dana-Farber Cancer Institute study shows. Researchers ...